← All organizations
Highest phase reached
Phase 4
First clinical trial
Sep 1, 2009Last known activity
Dec 30, 2025
Timeline
1990s
- Jun 1, 1994
Xiamen Amoytop Biotech Co., Ltd.— Founded
Drugs by trial phase (13 distinct, 27 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (6 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Recent trials (27)
- NCT07309562Lead sponsorPhase 3Dec 30, 2025
- NCT06927310Lead sponsorPhase 3Apr 28, 2025
- NCT06924385Lead sponsorPhase 1Apr 6, 2025
- NCT06893796Lead sponsorPhase 1Mar 26, 2025
- NCT06716905Lead sponsorPhase 1Jan 31, 2025
- NCT06552429Lead sponsorPhase 2Aug 31, 2024
- NCT06707922Lead sponsorN/AMar 18, 2022
- NCT05838885Lead sponsorPhase 2Feb 15, 2022
- NCT04885647Lead sponsorPhase 2Nov 12, 2020
- NCT04466137Lead sponsorPhase 3Jul 13, 2020
- NCT04846491Lead sponsorPhase 3Dec 4, 2019
- NCT04513171Lead sponsorPhase 2/Phase 3Dec 26, 2018
- NCT05451420CollaboratorN/ADec 1, 2017
- NCT02327416CollaboratorPhase 3Oct 1, 2014
- NCT02332473Lead sponsorPhase 2Jun 1, 2014
Details
- Founded
- Xiamen, CN Jun 1, 1994
- Last known activity
- Dec 30, 2025